DNMT3A and lymphoma: TFH lymphomas frequently harbor TET2 and DNMT3A mutations, and identical mutations have been identified in both the malignant T-cells and the myeloid component of patients, suggesting a common ancestral clone with subsequent divergent evolution [57].